STOCK TITAN

Know Labs SEC Filings

KNW NYSE

Know Labs, Inc. filings document the company's transition to USBC, Inc., public-company governance and capital-structure changes. Recent 8-K and proxy disclosures cover shareholder votes, amendments to articles of incorporation, an expanded equity incentive plan, private-placement and change-of-control matters, and material-event reporting tied to the company's corporate transformation.

The filing record also includes governance disclosures such as director and officer indemnification arrangements, capital-structure reporting for authorized common stock and equity issuances, and formal risk, operating and financial disclosures for the issuer's technology-development history and current corporate status.

Rhea-AI Summary

USBC, Inc. filed a Form D reporting a completed exempt equity offering under Rule 506(b). The filing states a total offering amount of $119,868,025, with the entire amount sold and $0 remaining. The issuer is a Nevada corporation with principal office in Reno. The offering closed with one investor reported. Cohen & Company Securities, LLC received a closing fee equal to 1% of post-closing common stock: 3,909,549 shares at $0.335 per share totaling $1,309,699 (recorded as sales commissions). The issuer indicates no proceeds were paid to listed officers, directors or promoters.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Linda Jenkinson, a director of the issuer, was granted an option to purchase 4,760,000 shares of the issuer's common stock on 08/06/2025 under the 2021 Equity Incentive Plan. The option has an exercise price of $2.45 per share and an expiration date of 08/06/2035. The option vests 25% on the one-year anniversary of the grant date, with the remainder vesting in quarterly installments over the following three years. The Form 4 was signed on 08/15/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Linda Jenkinson filed an Initial Statement on Form 3 reporting her relationship to the issuer as a Director of USBC, Inc. The filing shows the date of event as 08/06/2025 and is signed on 08/15/2025. The form states that no securities are beneficially owned by the reporting person. The filing lists a Reno, NV address for the reporting person and indicates the form was filed by one reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Chapman Kirk, Chief Operating Officer and Director of USBC, Inc. (USBC), was granted an option on August 6, 2025 to purchase 7,140,000 shares of the company's common stock at an exercise price of $2.45 per share. The option vests 25% on the one-year anniversary of the grant and then in quarterly installments over the following three years, and is exercisable through August 6, 2035. The Form 4 was signed on August 15, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Initial Form 3 filed by Kirk Chapman, Chief Operating Officer of USBC, Inc. The report states that the reporting person does not beneficially own any securities of the issuer. The filing identifies the reporting person's role as Officer and Director and confirms the Form 3 is an initial ownership disclosure required under Section 16.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

USBC, Inc., formerly known as Know Labs, Inc., reported several corporate changes and governance updates. The company adopted a new form of indemnification agreement for its directors and officers, providing indemnification to the fullest extent permitted by law and its governing documents, including advancement of expenses with reimbursement if indemnification is later found unwarranted. The company also maintains a directors’ and officers’ liability insurance policy covering certain securities law liabilities.

The company completed a change of its corporate name to USBC, Inc. and updated its trading symbol to “USBC” on the NYSE American, each effective August 15, 2025. In addition, the principal executive offices were relocated to Reno, Nevada.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Know Labs, Inc. issued 357,815,000 shares of its common stock to Goldeneye 1995 LLC in a private placement under a Securities Purchase Agreement dated June 5, 2025, with the closing on August 6, 2025. Goldeneye paid $15,000,000 in cash and 1,000 Bitcoin for the shares at a per-share price of $0.335. The issuance results in Goldeneye and Robert Gregory Kidd each being the beneficial owner of 357,815,000 shares, representing approximately 93.1% of the class based on 384,234,130 shares reported outstanding.

Following the closing, the company appointed Robert Gregory Kidd as Chief Executive Officer, President and Chairman and named Linda Jenkinson as Vice Chair. The filing discloses Voting and Support Agreements under which certain stockholders holding approximately 37% of the voting power agreed to vote to approve the Purchase Agreement. The Reporting Persons state they currently have no other specific plans beyond those disclosed, while reserving the right to buy, sell or transfer shares in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

On August 6, 2025 Know Labs issued 357,815,000 shares of common stock to Goldeneye 1995 LLC in a private placement at $0.335 per share, disclosed on an initial Form 3. The filing names Robert Gregory Kidd as sole owner and manager of the reporting entity and states he has voting control and investment discretion over the shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Know Labs filed a Form 3 reporting that Robert Gregory Kidd disclosed beneficial ownership of 357,815,000 common shares held indirectly through Goldeneye 1995 LLC. The shares were issued in a private placement on 08/06/2025 at a purchase price of $0.335 per share. Kidd is identified as a Director, an Officer (CEO, President, Chairman) and a 10% owner, and he is the sole owner and manager of Goldeneye with voting control and investment discretion over the shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

On August 6, 2025, Kitty B. Payne, an officer of Know Labs, Inc. (KNW), was granted an option to purchase 1,790,000 shares of the company's common stock at an exercise price of $2.45 per share under the 2021 Equity Incentive Plan. The option vests 25% on the one-year anniversary of the grant and then in quarterly installments over the following three years, tying vesting to continued service. The grant is reported as a direct ownership interest and the option shows an expiration date of August 6, 2035, indicating a 10-year term from the grant date. The Form 4 reports the transaction as an acquisition of derivative securities through the company plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Know Labs (KNW) SEC filings are available on StockTitan?

StockTitan tracks 23 SEC filings for Know Labs (KNW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Know Labs (KNW)?

The most recent SEC filing for Know Labs (KNW) was filed on August 21, 2025.